Does IL‐22 protect against liver fibrosis in hepatitis C virus infection?

E-ISSN： 1527-3350|62|6|1919-1919

ISSN： 0270-9139

Source： HEPATOLOGY, Vol.62, Iss.6, 2015-12, pp. : 1919-1919

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

IL‐22 and IL‐22 binding protein (IL‐22BP) regulate fibrosis and cirrhosis in hepatitis C virus and schistosome infections

HEPATOLOGY, Vol. 61, Iss. 4, 2015-04 ,pp. : 1321-1331

John Wiley & Sons Inc

Access to resources Recommend Favorite

Variations in serum sphingolipid levels associate with liver fibrosis progression and poor treatment outcome in hepatitis C virus but not hepatitis B virus infection

HEPATOLOGY, Vol. 61, Iss. 3, 2015-03 ,pp. : 812-822

John Wiley & Sons Inc

Access to resources Recommend Favorite

Screening for occult hepatitis C virus infection: Does it need special attention?

HEPATOLOGY, Vol. 62, Iss. 1, 2015-07 ,pp. : 321-322

John Wiley & Sons Inc

Access to resources Recommend Favorite

Editorial: the association of hepatitis C virus infection and post‐liver transplant diabetes

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 41, Iss. 5, 2015-03 ,pp. : 488-488

John Wiley & Sons Inc

Access to resources Recommend Favorite

Sofosbuvir and simeprevir for treatment of hepatitis C virus infection in liver transplant recipients

LIVER TRANSPLANTATION, Vol. 21, Iss. 6, 2015-06 ,pp. : 823-830

John Wiley & Sons Inc

Access to resources Recommend Favorite